1,404
Views
1
CrossRef citations to date
0
Altmetric
Research Article

In vitro study on the effect of peucedanol on the activity of cytochrome P450 enzymes

, , , &
Pages 935-940 | Received 12 Apr 2021, Accepted 13 Jun 2021, Published online: 10 Jul 2021

References

  • Chua YT, Ang XL, Zhong XM, Khoo KS. 2015. Interaction between warfarin and Chinese herbal medicines. Singapore Med J. 56(1):11–18.
  • Dong G, Zhou Y, Song X. 2018. In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes. Pharm Biol. 56(1):620–625.
  • Faria J, Solverson M, Faria M, Benoit M, McCormick M. 2019. Potential cytochrome P450 drug-drug interactions among pediatric patients undergoing tonsillectomy. Otolaryngol Head Neck Surg. 160(1):145–149.
  • Ge GB. 2019. Deciphering the metabolic fates of herbal constituents and the interactions of herbs with human metabolic system. Chin J Nat Med. 17(11):801–802.
  • Giri P, Gupta L, Naidu S, Joshi V, Patel N, Giri S, Srinivas NR. 2018. In vitro drug-drug interaction potential of sulfoxide and/or sulfone metabolites of albendazole, Triclabendazole, Aldicarb, Methiocarb, Montelukast and Ziprasidone. Drug Metab Lett. 12(2):101–116.
  • Guengerich FP, Waterman MR, Egli M. 2016. Recent structural insights into cytochrome P450 function. Trends Pharmacol Sci. 37(8):625–640.
  • Guo LQ, Taniguchi M, Xiao YQ, Baba K, Ohta T, Yamazoe Y. 2000. Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity. Jpn J Pharmacol. 82(2):122–129.
  • Hong MJ, Kim J. 2017. Determination of the absolute configuration of khellactone esters from Peucedanum japonicum roots. J Nat Prod. 80(5):1354–1360.
  • Huang YT, Onose J, Abe N, Yoshikawa K. 2009. In vitro inhibitory effects of pulvinic acid derivatives isolated from Chinese edible mushrooms, Boletus calopus and Suillus bovinus, on cytochrome P450 activity. Biosci Biotechnol Biochem. 73(4):855–860.
  • Lang J, Li W, Zhao J, Wang K, Chen D. 2017. Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes. Xenobiotica. 47(10):849–855.
  • Li J, Liang Q, Sun G. 2019. Interaction between traditional Chinese medicine and anticoagulant/antiplatelet drugs. Curr Drug Metab. 20(9):701–713.
  • Liu J, Zhang N, Li N, Fan X, Li Y. 2019. Influence of verapamil on the pharmacokinetics of oridonin in rats. Pharm Biol. 57(1):787–791.
  • Lynch T, Price A. 2007. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 76(3):391–396.
  • Ma BL, Ma YM. 2016. Pharmacokinetic herb-drug interactions with traditional Chinese medicine: progress, causes of conflicting results and suggestions for future research. Drug Metab Rev. 48(1):1–26.
  • MacLeod AK, McLaughlin LA, Henderson CJ, Wolf CR. 2017. Application of mice humanized for CYP2D6 to the study of tamoxifen metabolism and drug-drug interaction with antidepressants. Drug Metab Dispos. 45(1):17–22.
  • Nakajima M, Kobayashi K, Shimada N, Tokudome S, Yamamoto T, Kuroiwa Y. 1998. Involvement of CYP1A2 in mexiletine metabolism. Br J Clin Pharmacol. 46(1):55–62.
  • Nishihara M, Yamasaki H, Czerniak R, Jenkins H. 2019. In vitro assessment of potential for CYP-Inhibition-based drug-drug interaction between vonoprazan and clopidogrel. Eur J Drug Metab Pharmacokinet. 44(2):217–227.
  • Qi XY, Liang SC, Ge GB, Liu Y, Dong PP, Zhang JW, Wang AX, Hou J, Zhu LL, Yang L, et al. 2013. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes. Food Chem Toxicol. 56:392–397.
  • Rafaniello C, Sessa M, Bernardi FF, Pozzi M, Cheli S, Cattaneo D, Baldelli S, Molteni M, Bernardini R, Rossi F, et al. 2018. The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions. Pharmacogenomics J. 18(3):422–430.
  • Ren L, Du X, Hu M, Yan C, Liang T, Li Q. 2013. Design, synthesis and antitumor activity of novel 4-methyl-(3′S,4′S)-cis-khellactone derivatives. Molecules. 18(4):4158–4169.
  • Sarkhail P. 2014. Traditional uses, phytochemistry and pharmacological properties of the genus Peucedanum: a review. J Ethnopharmacol. 156:235–270.
  • Thelen K, Dressman JB. 2009. Cytochrome P450-mediated metabolism in the human gut wall. J Pharm Pharmacol. 61(5):541–558.
  • Urichuk L, Prior TI, Dursun S, Baker G. 2008. Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions. Curr Drug Metab. 9(5):410–418.
  • Yamamoto T, Furihata K, Hisaka A, Moritoyo T, Ogoe K, Kusayama S, Motohashi K, Mori A, Iwatsubo T, Suzuki H. 2017. Notable drug-drug interaction between etizolam and itraconazole in poor metabolizers of cytochrome P450 2C19. J Clin Pharmacol. 57(11):1491–1499.
  • Zhang JW, Liu Y, Cheng J, Li W, Ma H, Liu HT, Sun J, Wang LM, He YQ, Wang Y, et al. 2007. Inhibition of human liver cytochrome P450 by star fruit juice. J Pharm Pharm Sci. 10(4):496–503.
  • Zhang H, Ya G, Rui H. 2017. Inhibitory effects of triptolide on human liver cytochrome P450 enzymes and P-glycoprotein. Eur J Drug Metab Pharmacokinet. 42(1):89–98.
  • Zhu Y, Wang F, Li Q, Zhu M, Du A, Tang W, Chen W. 2014. Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation. Drug Metab Dispos. 42(2):245–249.